Pangea Bio

Drug Discovery · Kent, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of a novel medicines platform designed to treat neurological disorders. Pangea Bio is based in Kent, United Kingdom and was founded in 2021. It was valued at $80 million at its early-stage round in Oct 2024, the last priced event on record. It has raised $21.7 million across 1 recorded round; the latest was a $15.6 million Series A in Oct 2023.

PMV mark · valuation
$80.0M
Oct 2026
Priced at
its early-stage round
Oct 2024
Total raised
$21.7M
Last round
Early Stage VC (Series A)
Oct 2023
How much has Pangea Bio raised?
$21.7Macross 1 recorded rounds · Oct 2023 – Oct 2023

Most recently, Pangea Bio raised $15.6M in its Early Stage VC (Series A) (Oct 2023).

Free account
More of Pangea Bio with a free account
  • ·The complete investor list: 19 names
  • ·Watch Pangea Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pangea Bio round by round

1 rounds
Oct 2023Early Stage VC (Series A)$15.6M▮
+ 1 more investors · free account

How much has Pangea Bio raised?

Pangea Bio has raised $21.7 million in total; 1 of its rounds is on record. The largest on record was a $15.6 million Series A in Oct 2023.

Pangea Bio investors

19 investors are on record for Pangea Bio, including Plug and Play Tech Center, Innovate UK, Metaplanet Holdings and London & Partners.. The Series A in Oct 2023 drew 4 investors.

For fundraisers
Raising for a company like Pangea Bio?

19 investors have backed Pangea Bio — start your target list with the firms already writing checks in drug discovery.

See all 19 investors →

Frequently asked about Pangea Bio

How much has Pangea Bio raised?
Pangea Bio has raised $21.7M in total across 1 recorded funding rounds.
When was Pangea Bio's last funding round?
Pangea Bio's most recent recorded round was Early Stage VC (Series A) in Oct 2023, raising $15.6M.
Pangea Bio Funding Rounds & Investors — $21.7M Raised | Premier Alternatives